New research foundation commits $500M to funding ‘long bets’ in sciencenews2025-08-27T14:00:25+00:00August 27th, 2025|Endpoints News|
Wugen collects $115M as it runs pivotal allogeneic CAR-T trialnews2025-08-27T11:00:58+00:00August 27th, 2025|Endpoints News|
BioXcel to seek label update for psych drug Igalmi after Phase 3 successnews2025-08-27T11:00:24+00:00August 27th, 2025|Endpoints News|
Antiva to tweak dosing of HPV drug, seek funding for new trial following mixed early datanews2025-08-27T11:00:12+00:00August 27th, 2025|Endpoints News|
US officials link tariffs with drug pricing talksnews2025-08-26T19:53:10+00:00August 26th, 2025|Endpoints News|
PhRMA loses fight over Oregon drug price transparency lawnews2025-08-26T19:37:40+00:00August 26th, 2025|Endpoints News|
Vinay Prasad drops two of his titles in return to FDAnews2025-08-26T19:20:49+00:00August 26th, 2025|Endpoints News|
Sanofi hires Novartis veteran as chief medical officernews2025-08-26T17:28:03+00:00August 26th, 2025|Endpoints News|
Healthcare AI reaches a maturity momentnews2025-08-26T17:08:14+00:00August 26th, 2025|Endpoints News|
Akeso says its PD-1xVEGF hit OS significance in China studynews2025-08-26T16:41:10+00:00August 26th, 2025|Endpoints News|
